Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)

The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousaf, Zohaib, Ata, Fateen, Mohammed Hammamy, Riyadh Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013693/
http://dx.doi.org/10.1016/j.tru.2022.100104
_version_ 1784688051426951168
author Yousaf, Zohaib
Ata, Fateen
Mohammed Hammamy, Riyadh Ali
author_facet Yousaf, Zohaib
Ata, Fateen
Mohammed Hammamy, Riyadh Ali
author_sort Yousaf, Zohaib
collection PubMed
description The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has been the development of widespread thrombosis with viral-vectored vaccines. We present a case of extensive thrombosis associated with the messenger RNA (m-RNA) vaccine.
format Online
Article
Text
id pubmed-9013693
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90136932022-04-18 Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) Yousaf, Zohaib Ata, Fateen Mohammed Hammamy, Riyadh Ali Thrombosis Update Article The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has been the development of widespread thrombosis with viral-vectored vaccines. We present a case of extensive thrombosis associated with the messenger RNA (m-RNA) vaccine. The Authors. Published by Elsevier Ltd. 2022-05 2022-04-18 /pmc/articles/PMC9013693/ http://dx.doi.org/10.1016/j.tru.2022.100104 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Yousaf, Zohaib
Ata, Fateen
Mohammed Hammamy, Riyadh Ali
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title_full Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title_fullStr Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title_full_unstemmed Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title_short Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
title_sort thrombosis post-mrna-based sars-cov-2 vaccination (bnt162b2) – time to think beyond thrombosis with thrombocytopenia syndrome (tts)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013693/
http://dx.doi.org/10.1016/j.tru.2022.100104
work_keys_str_mv AT yousafzohaib thrombosispostmrnabasedsarscov2vaccinationbnt162b2timetothinkbeyondthrombosiswiththrombocytopeniasyndrometts
AT atafateen thrombosispostmrnabasedsarscov2vaccinationbnt162b2timetothinkbeyondthrombosiswiththrombocytopeniasyndrometts
AT mohammedhammamyriyadhali thrombosispostmrnabasedsarscov2vaccinationbnt162b2timetothinkbeyondthrombosiswiththrombocytopeniasyndrometts

Ejemplares similares